Two weeks after treatment with SBRT alone, the results showed increased tumor densities of CD3+ T cells, FoxP3+ Tregs, and CD204+ macrophages, along with increased expression of genes associated with immunosuppression. Here, FOXP3 is linked to neoplasm.